When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   This second medication in this combination is the synthetic inhaled corticosteroid fluticasone furoate. This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta.

3. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/...

   The combination fluticasone furoate/umeclidinium bromide/vilanterol product is approved by the US Food and Drug Administration with an indication for the maintenance treatment of a chronic lung problem called chronic obstructive pulmonary disease (COPD) in adults who (1) have already tried fluticasone furoate/vilanterol (brand name Breo Ellipta) but are still experiencing symptoms of airway ...

4. Beta blocker - Wikipedia

   en.wikipedia.org/wiki/Beta_blocker

   Beta blockers vary in their lipophilicity (fat solubility) and in turn in their ability to cross the blood–brain barrier and exert effects in the central nervous system. [76] Beta blockers with greater blood–brain barrier permeability can have both neuropsychiatric therapeutic benefits and side effects, as well as adverse cognitive effects ...

5. Levobunolol - Wikipedia

   en.wikipedia.org/wiki/Levobunolol

   Like other non-selective beta blockers, levobunolol is contraindicated in patients with airway diseases such as asthma and severe chronic obstructive pulmonary disease (COPD), as well as heart problems such as sinus bradycardia, second- or third-degree atrioventricular block, sick sinus syndrome, and cardiogenic shock.

6. Adrenergic neuron blockers - Wikipedia

   en.wikipedia.org/wiki/Adrenergic_neuron_blockers

   While some studies suggest that there are minimal differences in side effects between asthma patients and non-asthma patients, beta 1 blockers are generally avoided in patients with asthma or chronic obstructive pulmonary disease due to their potential to block beta 2 receptors, particularly at high doses. [4] Presentations of asthma

7. Beclometasone/formoterol/glycopyrronium bromide - Wikipedia

   en.wikipedia.org/wiki/Beclometasone/formoterol/...

   Formoterol is a long-acting beta-2 agonist. [3] [4] It attaches to receptors (targets) known as beta-2 receptors in the muscles of the airways. [3] [4] By attaching to these receptors, it causes the muscles to relax, which keeps the airways open and helps with the patient's breathing. [3] [4] Glycopyrronium bromide is a muscarinic receptor ...